- Investing Ideas
- /
- South Korean Pharmaceuticals & Biotech Leverage Leaders
South Korean Pharmaceuticals & Biotech Leverage Leaders
Results
10
10 companies
Hanmi Pharm
Market Cap: ₩3.7t
A biopharmaceutical company, engages in the manufacture and sale of pharmaceutical products in South Korea, China, Japan, the United States, and internationally.
A128940
₩293,000.00
7D
7.9%
1Y
-9.7%
Peptron
Market Cap: ₩4.6t
Engages in the development of peptide-based medicines.
A087010
₩197,800.00
7D
19.0%
1Y
531.9%
Hugel
Market Cap: ₩3.7t
Develops and manufactures biopharmaceuticals in South Korea and internationally.
A145020
₩346,500.00
7D
-3.1%
1Y
72.0%
SK Biopharmaceuticals
Market Cap: ₩7.1t
A pharmaceutical company, engages in the research and development of drugs for the treatment of central nervous system disorders.
A326030
₩90,700.00
7D
0.3%
1Y
1.2%
ALTEOGEN
Market Cap: ₩16.9t
A bio company, focuses on developing long-acting biobetters, proprietary antibody-drug conjugates, and antibody biosimilars.
A196170
₩317,500.00
7D
-8.0%
1Y
67.5%
Samsung BiologicsLtd
Market Cap: ₩71.3t
Together with its subsidiaries engages in the manufacturing of biopharmaceuticals products in South Korea, Europe, the United States, and internationally.
A207940
₩1,002,000.00
7D
-3.7%
1Y
27.2%
Celltrion
Market Cap: ₩32.8t
Develops and produces drugs based on proteins for the treatment of oncology in South Korea.
A068270
₩154,000.00
7D
-2.5%
1Y
-15.6%
LigaChem Biosciences
Market Cap: ₩3.7t
A clinical stage biopharmaceutical company, engages in the discovery and development of medicines for unmet medical needs.
A141080
₩103,100.00
7D
4.2%
1Y
50.1%
PharmaResearch
Market Cap: ₩4.3t
Operates as a biopharmaceutical company primarily in South Korea.
A214450
₩416,000.00
7D
3.6%
1Y
202.1%
Sam Chun Dang Pharm
Market Cap: ₩3.4t
Engages in the manufacturing and sale of pharmaceutical products in South Korea.
A000250
₩148,000.00
7D
6.1%
1Y
31.8%